Skip to main content

Advertisement

Log in

Cyclosporine-induced retinal toxic blindness

  • Case Report
  • Published:
Bone Marrow Transplantation Submit manuscript

Abstract

We report the case of a BMT recipient who developed blindness 2½ months after BMT. Microvascular retinopathy, cortical blindness and other ocular pathologies were excluded with appropriate tests. Electrophysiological studies showed retinal damage without excluding an optic nerve lesion. The patient, who had several risk factors for neurologic-induced cyclosporine toxicity, improved with cyclosporine withdrawal. Our findings stress the need of electrophysiological tests to exclude neuroretinal damage in patients receiving cyclosporine after BMT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

López-Jiménez, J., Sánchez, A., Fernández, C. et al. Cyclosporine-induced retinal toxic blindness. Bone Marrow Transplant 20, 243–245 (1997). https://doi.org/10.1038/sj.bmt.1700878

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1700878

  • Springer Nature Limited

Keywords

This article is cited by

Navigation